Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

512 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.
Masaki Y, Kawabata H, Takai K, Kojima M, Tsukamoto N, Ishigaki Y, Kurose N, Ide M, Murakami J, Nara K, Yamamoto H, Ozawa Y, Takahashi H, Miura K, Miyauchi T, Yoshida S, Momoi A, Awano N, Ikushima S, Ohta Y, Furuta N, Fujimoto S, Kawanami H, Sakai T, Kawanami T, Fujita Y, Fukushima T, Nakamura S, Kinoshita T, Aoki S. Masaki Y, et al. Among authors: tsukamoto n. Int J Hematol. 2016 Jun;103(6):686-92. doi: 10.1007/s12185-016-1979-1. Epub 2016 Mar 18. Int J Hematol. 2016. PMID: 27084250
Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?
Fujimoto S, Sakai T, Kawabata H, Kurose N, Yamada S, Takai K, Aoki S, Kuroda J, Ide M, Setoguchi K, Tsukamoto N, Iwao-Kawanami H, Kawanami T, Mizuta S, Fukushima T, Masaki Y. Fujimoto S, et al. Among authors: tsukamoto n. Am J Hematol. 2019 Sep;94(9):975-983. doi: 10.1002/ajh.25554. Epub 2019 Jun 21. Am J Hematol. 2019. PMID: 31222819 Free article. Clinical Trial.
2019 Updated diagnostic criteria and disease severity classification for TAFRO syndrome.
Masaki Y, Kawabata H, Takai K, Tsukamoto N, Fujimoto S, Ishigaki Y, Kurose N, Miura K, Nakamura S, Aoki S; Japanese TAFRO Syndrome Research Team. Masaki Y, et al. Among authors: tsukamoto n. Int J Hematol. 2020 Jan;111(1):155-158. doi: 10.1007/s12185-019-02780-1. Epub 2019 Nov 28. Int J Hematol. 2020. PMID: 31782045 No abstract available.
Optimal treatments for TAFRO syndrome: a retrospective surveillance study in Japan.
Fujimoto S, Kawabata H, Sakai T, Yanagisawa H, Nishikori M, Nara K, Ohara S, Tsukamoto N, Kurose N, Yamada S, Takai K, Aoki S, Masaki Y. Fujimoto S, et al. Among authors: tsukamoto n. Int J Hematol. 2021 Jan;113(1):73-80. doi: 10.1007/s12185-020-03008-3. Epub 2020 Sep 24. Int J Hematol. 2021. PMID: 32970275
Patient's age and D-dimer levels predict the prognosis in patients with TAFRO syndrome.
Kawabata H, Fujimoto S, Sakai T, Yanagisawa H, Kitawaki T, Nara K, Hagihara M, Yamamoto H, Tanimizu M, Kato C, Origuchi T, Sunami K, Sunami Y, Masunari T, Nakamura N, Kobayashi M, Yamagami K, Miura K, Takai K, Aoki S, Tsukamoto N, Masaki Y. Kawabata H, et al. Among authors: tsukamoto n. Int J Hematol. 2021 Aug;114(2):179-188. doi: 10.1007/s12185-021-03159-x. Epub 2021 Apr 30. Int J Hematol. 2021. PMID: 33929719 Free PMC article.
Correction to: Patient's age and D‑dimer levels predict the prognosis in patients with TAFRO syndrome.
Kawabata H, Fujimoto S, Sakai T, Yanagisawa H, Kitawaki T, Nara K, Hagihara M, Yamamoto H, Tanimizu M, Kato C, Origuchi T, Sunami K, Sunami Y, Masunari T, Nakamura N, Kobayashi M, Yamagami K, Miura K, Takai K, Aoki S, Tsukamoto N, Masaki Y. Kawabata H, et al. Among authors: tsukamoto n. Int J Hematol. 2021 Aug;114(2):301-302. doi: 10.1007/s12185-021-03170-2. Int J Hematol. 2021. PMID: 34061294 Free PMC article. No abstract available.
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details.
Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Sumida T, Mimori T, Tanaka Y, Tsubota K, Yoshino T, Kawa S, Suzuki R, Takegami T, Tomosugi N, Kurose N, Ishigaki Y, Azumi A, Kojima M, Nakamura S, Inoue D; Research Program for Intractable Disease by Ministry of Health, Labor and Welfare (MHLW) Japan G4 team. Umehara H, et al. Mod Rheumatol. 2012 Feb;22(1):1-14. doi: 10.1007/s10165-011-0508-6. Epub 2011 Sep 1. Mod Rheumatol. 2012. PMID: 21881964 Free PMC article. Review.
Retrospective analysis of prognostic factors for Waldenstrӧm macroglobulinemia: a multicenter cooperative study in Japan.
Saito A, Isoda A, Kojima M, Yokohama A, Tsukune Y, Sasaki M, Ito S, Ohtsu A, Koike M, Murayama K, Moriya K, Tamura H, Matsumoto M, Nakahashi H, Tanosaki S, Sakura T, Kawamura T, Miyanaga T, Nakamura N, Murakami H, Handa H, Tsukamoto N. Saito A, et al. Among authors: tsukamoto n. Int J Hematol. 2017 Nov;106(5):681-690. doi: 10.1007/s12185-017-2297-y. Epub 2017 Jul 7. Int J Hematol. 2017. PMID: 28687991 Clinical Trial.
512 results